<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="427025-2019" EDITION="2019175"><TECHNICAL_SECTION><RECEPTION_ID>19-435508-001</RECEPTION_ID><DELETION_DATE>20190926</DELETION_DATE><FORM_LG_LIST>PT </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>175</NO_OJ><DATE_PUB>20190911</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2019/S 175-427025</NO_DOC_OJS><URI_LIST><URI_DOC LG="PT">http://ted.europa.eu/udl?uri=TED:NOTICE:427025-2019:TEXT:PT:HTML</URI_DOC></URI_LIST><LG_ORIG>PT</LG_ORIG><ISO_COUNTRY VALUE="PT"/><IA_URL_GENERAL>http://www.chln.min-saude.pt</IA_URL_GENERAL><ORIGINAL_CPV CODE="33632100">Anti-inflammatory and anti-rheumatic products</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="PT170">Área Metropolitana de Lisboa</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="PT170">Área Metropolitana de Lisboa</n2016:CA_CE_NUTS><REF_NOTICE><NO_DOC_OJS>2019/S 113-277957</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20190906</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="2">Additional information</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="4">Services</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01C14</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Пopтyгaлия</TI_CY><TI_TOWN>Лисабон</TI_TOWN><TI_TEXT><P>Противовъзпалителни и противоревматични медикаменти</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Portugalsko</TI_CY><TI_TOWN>Lisabon</TI_TOWN><TI_TEXT><P>Antirevmatika a protizánětlivé léky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT><P>Antiinflammatoriske og antireumatiske midler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT><P>Antiphlogistika und Antirheumatika</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Πορτογαλία</TI_CY><TI_TOWN>Λισσαβόνα</TI_TOWN><TI_TEXT><P>Αντιφλεγμονώδη και φάρμακα ρευματικών νόσων</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisbon</TI_TOWN><TI_TEXT><P>Anti-inflammatory and anti-rheumatic products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisboa</TI_TOWN><TI_TEXT><P>Antiinflamatorios y antirreumáticos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT><P>Põletikuvastased ja reumavastased tooted</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Portugali</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT><P>Tulehduskipu- ja reumalääkkeet</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisbonne</TI_TOWN><TI_TEXT><P>Anti-inflammatoires et antirhumatismaux</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Phortaingéil, an</TI_CY><TI_TOWN>Liospóin</TI_TOWN><TI_TEXT><P>Anti-inflammatory and anti-rheumatic products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisabon</TI_TOWN><TI_TEXT><P>Protuupalni i antireumatski lijekovi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Portugália</TI_CY><TI_TOWN>Lisszabon</TI_TOWN><TI_TEXT><P>Gyulladáscsökkentők és antireumatikumok</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Portogallo</TI_CY><TI_TOWN>Lisbona</TI_TOWN><TI_TEXT><P>Prodotti antinfiammatori e antireumatici</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Portugalija</TI_CY><TI_TOWN>Lisabona</TI_TOWN><TI_TEXT><P>Priešuždegiminiai ir priešreumatiniai vaistai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Portugāle</TI_CY><TI_TOWN>Lisabona</TI_TOWN><TI_TEXT><P>Pretiekaisuma un pretreimatisma izstrādājumi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>il-Portugall</TI_CY><TI_TOWN>Liżbona</TI_TOWN><TI_TEXT><P>Prodotti kontra l-infamazzjoni u anti-rewmatiċi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT><P>Ontstekingremmende en reumabestrijdende preparaten</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Portugalia</TI_CY><TI_TOWN>Lizbona</TI_TOWN><TI_TEXT><P>Produkty przeciwzapalne i przeciwreumatyczne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Portugal</TI_CY><TI_TOWN>Lisboa</TI_TOWN><TI_TEXT><P>Anti-inflamatórios e anti-reumatismais</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Portugalia</TI_CY><TI_TOWN>Lisabona</TI_TOWN><TI_TEXT><P>Antiinflamatoare şi antireumatismale</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Portugalsko</TI_CY><TI_TOWN>Lisabon</TI_TOWN><TI_TEXT><P>Protizápalové a protireumatické prípravky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Portugalska</TI_CY><TI_TOWN>Lizbona</TI_TOWN><TI_TEXT><P>Zdravila s protivnetnim in protirevmatičnim učinkom</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Portugal</TI_CY><TI_TOWN>Lissabon</TI_TOWN><TI_TEXT><P>Antiinflammatoriska och antireumatiska medel</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="PT">Centro Hospitalar Universitário de Lisboa Norte, E. P. E.</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F14_2014 CATEGORY="ORIGINAL" FORM="F14" LG="PT"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Centro Hospitalar Universitário de Lisboa Norte, E. P. E.</OFFICIALNAME><TOWN>Lisboa</TOWN><POSTAL_CODE>1649-035</POSTAL_CODE><COUNTRY VALUE="PT"/><CONTACT_POINT>Ana Taklim Nave</CONTACT_POINT><E_MAIL>ana.nave@chln.min-saude.pt</E_MAIL><n2016:NUTS CODE="PT170"/><URL_GENERAL>http://www.chln.min-saude.pt</URL_GENERAL><URL_BUYER>http://www.chln.min-saude.pt</URL_BUYER></ADDRESS_CONTRACTING_BODY></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Ajuste Direto número 191g002250</P></TITLE><CPV_MAIN><CPV_CODE CODE="33632100"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SERVICES"/><SHORT_DESCR><P>Etenercept caneta e seringa AD-2019-37.</P></SHORT_DESCR></OBJECT_CONTRACT><COMPLEMENTARY_INFO><DATE_DISPATCH_NOTICE>2019-09-06</DATE_DISPATCH_NOTICE><NOTICE_NUMBER_OJ>2019/S 113-277957</NOTICE_NUMBER_OJ></COMPLEMENTARY_INFO><CHANGES><CHANGE PUBLICATION="YES"><WHERE><SECTION>II.1.7)</SECTION><LABEL>Valor total do concurso (sem IVA)</LABEL></WHERE><OLD_VALUE><TEXT><P>1 326 742,70 EUR</P></TEXT></OLD_VALUE><NEW_VALUE><TEXT><P>880 393,93 EUR</P></TEXT></NEW_VALUE></CHANGE></CHANGES></F14_2014></FORM_SECTION></TED_EXPORT>